Meet & Match – Microbiome & Health
BIOPRO Baden-Württemberg GmbH und BioValley France laden Sie ein am 1. Juli 2021 bei der 19. Ausgabe unserer gemeinsamen Netzwerk-Veranstaltung «Meet & Match» dabei zu sein. Freuen Sie sich auf spannende Online-Vorträge und die Gelegenheit sich zu vernetzen oder Kooperationspartner zu finden.
Zielgruppe
Wissenschaftler & forschende Unternehmen mit Interesse auf dem Gebiet der Mikrobiomforschung, -analyse, -diagnostik und entsprechender Anwendungen
Veranstalter
BIOPRO Baden-Württemberg & BioValley France
Kontakt
BIOPRO:
Dr. Sandra Sapich
E-Mail: sapich(at)bio-pro.de
Jana Friedl
E-Mail: friedl(at)bio-pro.de
BioValley France:
Agnès Legoll
E-Mail: agnes.legoll(at)biovalley-france.com
Folgende Informationen sind lediglich auf Englisch verfügbar:
Topics
The human microbiome has been linked to a number of conditions and diseases including diabetes, autism, anxiety and obesity. Other important roles of the human microbiome include programming the immune system, providing nutrients for cells and preventing colonisation by pathogens. Thus, the analysis and research of different microbial communities living inside or outside of the human body could be key to our health. To further address this hot topic, BIOPRO and their French partner BioValley France organise their 19th joint «Meet & Match» event, focusing on the «Microbiome». The virtual event takes place on Thursday, July 1, 2021.
Thematically, the focus of this networking event is on opportunities and possibilities in the field of microbiome research and analysis. Presentations from researchers, clinicians and industry will provide further insight into exciting projects featuring different therapeutic and diagnostic approaches.
Why participate?
The Meet & Match addresses research institutions, companies and start-ups – mainly from France and Baden-Württemberg – with an interest in methods, treatments and diseases linked to the human microbiome. The objective of the event is to establish new contacts, encourage participants to initiate cooperations or joint developments as well as to gain a better understanding of the microbiome's impact on human health.
Registration
The participation is free of charge. For organisational reasons, prior registration is requested. Therefore, please fill in the registration form (soon available here).
You will receive more information about the online platform prior to the event. Please note that the number of participants is limited.
We look forward to meet you online!
Programme
09:00 - 9:30 | Login
09:30 - 9:40 | Welcome & introduction
- Dr. Sandra Sapich, BIOPRO Baden-Württemberg and Agnès Legoll, BioValley France
9:40 - 10:10 | Keynote from BW
- Microbiome in Health and Disease: Gut microbes revolutionizing cancer medicine
Dr. Christoph Stein-Thoeringer
Deutsches Krebsforschungszentrum (DKFZ), Division of Microbiome and Cancer, Heidelberg
10:10 - 10:40 | Keynote from France
- From gut flora to the microbiome revolution : what do we know about this neglected organ and its importance for Human health
Hervé M. Blottière, PhD
French National Research Institute for Agricultural and Food Research (INRAE), Pathophysiology of Nutritional Adaptations (UMR 1280), Paris
10:45 - 11:15 | Session I
- Patient microbiota modulation by fecal transplantation
Prof. Dr. Florian Fricke
Universität Hohenheim, Microbiome and Applied Bioinformatics, Stuttgart
- Diversity Matters! MaaT Pharma’s Microbiome Ecosystem Therapies in Graft-vs-host-Disease and Oncology
Dr. Savita Bernal
MaaT Pharma, Lyon
11:20 - 11:30 | Coffee break
11:30 - 11:55 | Pitch session I
- Dr. Oliver Deusch
Computomics, Tübingen
- Dr. Stephanie Badel
Biofilm Control, Saint Beauzire
- Prof. Dr. David Schleheck
University of Konstanz, Konstanz
- Dr. Romain Daillere
EverImmune, Villejuif
- Dr. Sylvie Maubant
Oncodesign, Dijon Cedex
11:55 - 12:40 | Session II
- Exploring the human microbiome from a genomic perspective
Dr. Robert Finn
EMBL-EBI, Cambridge
- Harnessing the Power of Gut Keystone Bacteria into Ground-Breaking Biotherapies
Georges Rawadi, PhD
Ysopia Bioscience, Bordeaux
- Assessing beneficial effects of probiotics in small animal models: ETAP-Lab’s experience
Jean-François Bisson, PhD
EtapLab, Vandoeuvre Les Nancy
12:40 - 12:50 | Coffee break
12:50 - 13:15 | Pitch session II
- Dr. Andrew Clark
University of Stuttgart, Stuttgart
- Dr. Tania Sorg
Phenomin, Illkirch-Graffenstaden
- Clarisse Meneghel
Smaltis, Besançon
- Dr. Vladimir Jakovjevic
Microbiome Power, Heidelberg
13:15 - 14:00 | Closing remarks & networking
14:00 | End of event
